A Case of Severe Cholestasis due to Hepatic AL Amyloidosis
Introduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and...
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Karger Publishers
2019-02-01
|
Series: | GE: Portuguese Journal of Gastroenterology |
Subjects: | |
Online Access: | https://www.karger.com/Article/FullText/496185 |
id |
doaj-5f2d49428cc54decb27a26ac246f01f4 |
---|---|
record_format |
Article |
spelling |
doaj-5f2d49428cc54decb27a26ac246f01f42020-11-25T03:56:17ZengKarger PublishersGE: Portuguese Journal of Gastroenterology2341-45452387-19542019-02-011510.1159/000496185496185A Case of Severe Cholestasis due to Hepatic AL AmyloidosisTeresa DiasDiana FerreiraHélder MoreiraTelma NascimentoArsénio SantosArmando CarvalhoIntroduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and severe intrahepatic cholestasis as the primary manifestation of the disease is rare. Clinical Case: We report an unusual case of primary amyloidosis in a 71-year-old man, presenting with rapidly progressive cholestasis, associated with hepatomegaly. There are a few reported cases in the literature of cholestasis and acute liver failure as the first manifestations of AL amyloidosis. Conclusion: Infiltrative diseases, such as amyloidosis, must be considered when a patient presents with cholestatic hepatitis. A liver biopsy is essential for the diagnosis of amyloidosis when liver test abnormalities dominate the initial clinical presentation. Liver involvement in patients with amyloidosis is often an indicator of poor prognosis.https://www.karger.com/Article/FullText/496185CholestasisAmyloidosisLiverMyeloma |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Teresa Dias Diana Ferreira Hélder Moreira Telma Nascimento Arsénio Santos Armando Carvalho |
spellingShingle |
Teresa Dias Diana Ferreira Hélder Moreira Telma Nascimento Arsénio Santos Armando Carvalho A Case of Severe Cholestasis due to Hepatic AL Amyloidosis GE: Portuguese Journal of Gastroenterology Cholestasis Amyloidosis Liver Myeloma |
author_facet |
Teresa Dias Diana Ferreira Hélder Moreira Telma Nascimento Arsénio Santos Armando Carvalho |
author_sort |
Teresa Dias |
title |
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis |
title_short |
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis |
title_full |
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis |
title_fullStr |
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis |
title_full_unstemmed |
A Case of Severe Cholestasis due to Hepatic AL Amyloidosis |
title_sort |
case of severe cholestasis due to hepatic al amyloidosis |
publisher |
Karger Publishers |
series |
GE: Portuguese Journal of Gastroenterology |
issn |
2341-4545 2387-1954 |
publishDate |
2019-02-01 |
description |
Introduction: Immunoglobulin light chain-associated amyloidosis results from extracellular tissue deposition of fibril-forming monoclonal immunoglobulin light chains, secreted by a clone of plasma cells. Although the liver is often involved histologically, most cases are clinically asymptomatic, and severe intrahepatic cholestasis as the primary manifestation of the disease is rare. Clinical Case: We report an unusual case of primary amyloidosis in a 71-year-old man, presenting with rapidly progressive cholestasis, associated with hepatomegaly. There are a few reported cases in the literature of cholestasis and acute liver failure as the first manifestations of AL amyloidosis. Conclusion: Infiltrative diseases, such as amyloidosis, must be considered when a patient presents with cholestatic hepatitis. A liver biopsy is essential for the diagnosis of amyloidosis when liver test abnormalities dominate the initial clinical presentation. Liver involvement in patients with amyloidosis is often an indicator of poor prognosis. |
topic |
Cholestasis Amyloidosis Liver Myeloma |
url |
https://www.karger.com/Article/FullText/496185 |
work_keys_str_mv |
AT teresadias acaseofseverecholestasisduetohepaticalamyloidosis AT dianaferreira acaseofseverecholestasisduetohepaticalamyloidosis AT heldermoreira acaseofseverecholestasisduetohepaticalamyloidosis AT telmanascimento acaseofseverecholestasisduetohepaticalamyloidosis AT arseniosantos acaseofseverecholestasisduetohepaticalamyloidosis AT armandocarvalho acaseofseverecholestasisduetohepaticalamyloidosis AT teresadias caseofseverecholestasisduetohepaticalamyloidosis AT dianaferreira caseofseverecholestasisduetohepaticalamyloidosis AT heldermoreira caseofseverecholestasisduetohepaticalamyloidosis AT telmanascimento caseofseverecholestasisduetohepaticalamyloidosis AT arseniosantos caseofseverecholestasisduetohepaticalamyloidosis AT armandocarvalho caseofseverecholestasisduetohepaticalamyloidosis |
_version_ |
1724465893756370944 |